Evolving drug delivery strategies to overcome the blood brain barrier
DS Hersh, AS Wadajkar, NB Roberts… - Current …, 2016 - ingentaconnect.com
The blood-brain barrier (BBB) poses a unique challenge for drug delivery to the central
nervous system (CNS). The BBB consists of a continuous layer of specialized endothelial …
nervous system (CNS). The BBB consists of a continuous layer of specialized endothelial …
[HTML][HTML] Convection-enhanced delivery
AM Mehta, AM Sonabend, JN Bruce - Neurotherapeutics, 2017 - Elsevier
Convection-enhanced delivery (CED) is a promising technique that generates a pressure
gradient at the tip of an infusion catheter to deliver therapeutics directly through the …
gradient at the tip of an infusion catheter to deliver therapeutics directly through the …
The basal forebrain regulates global resting-state fMRI fluctuations
Patterns of spontaneous brain activity, typically measured in humans at rest with fMRI, are
used routinely to assess the brain's functional organization. The mechanisms that generate …
used routinely to assess the brain's functional organization. The mechanisms that generate …
ABC transporters at the blood–brain interfaces, their study models, and drug delivery implications in gliomas
D Gomez-Zepeda, M Taghi, JM Scherrmann… - Pharmaceutics, 2019 - mdpi.com
Drug delivery into the brain is regulated by the blood–brain interfaces. The blood–brain
barrier (BBB), the blood–cerebrospinal fluid barrier (BCSFB), and the blood–arachnoid …
barrier (BBB), the blood–cerebrospinal fluid barrier (BCSFB), and the blood–arachnoid …
Convection-enhanced delivery to the central nervous system
RR Lonser, M Sarntinoranont, PF Morrison… - Journal of …, 2015 - thejns.org
Convection-enhanced delivery (CED) is a bulk flow–driven process. Its properties permit
direct, homogeneous, targeted perfusion of CNS regions with putative therapeutics while …
direct, homogeneous, targeted perfusion of CNS regions with putative therapeutics while …
Trial of magnetic resonance–guided putaminal gene therapy for advanced Parkinson's disease
JD Heiss, C Lungu, DA Hammoud… - Movement …, 2019 - Wiley Online Library
Objective To investigate the safety and tolerability of convection‐enhanced delivery of an
adeno‐associated virus, serotype‐2 vector carrying glial cell line‐derived neurotrophic …
adeno‐associated virus, serotype‐2 vector carrying glial cell line‐derived neurotrophic …
Bidirectional control of social behavior by activity within basolateral and central amygdala of primates
LL Wellman, PA Forcelli, BL Aguilar… - Journal of …, 2016 - Soc Neuroscience
Both hypoactivity and hyperactivity in the amygdala are associated with perturbations in
social behavior. While> 60 years of experimental manipulations of the amygdala in animal …
social behavior. While> 60 years of experimental manipulations of the amygdala in animal …
First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1
MA Vogelbaum, C Brewer, GH Barnett… - Journal of …, 2018 - thejns.org
OBJECTIVE Progress in management of high-grade gliomas (HGGs) has been hampered
by poor access of potential therapeutics to the CNS. The Cleveland Multiport Catheter …
by poor access of potential therapeutics to the CNS. The Cleveland Multiport Catheter …
Defense-like behaviors evoked by pharmacological disinhibition of the superior colliculus in the primate
JT DesJardin, AL Holmes, PA Forcelli… - Journal of …, 2013 - Soc Neuroscience
Stimulation of the intermediate and deep layers of superior colliculus (DLSC) in rodents
evokes both orienting/pursuit (approach) and avoidance/flight (defense) responses. These …
evokes both orienting/pursuit (approach) and avoidance/flight (defense) responses. These …
Promising approaches to circumvent the blood–brain barrier: progress, pitfalls and clinical prospects in brain cancer
IT Papademetriou, T Porter - Therapeutic delivery, 2015 - Taylor & Francis
Brain drug delivery is a major challenge for therapy of central nervous system (CNS)
diseases. Biochemical modifications of drugs or drug nanocarriers, methods of local …
diseases. Biochemical modifications of drugs or drug nanocarriers, methods of local …